Independent wellness intelligence.
Search peptide companies, laboratories, clinics, providers and products against public sources, lab reports, regulatory records and investigations — all in one place.
Most Reported
Entity Categories
Sourced from Retatrutide Supplier OSINT Intelligence — July 2026.
China / China-facing brands and factories flagged in the OSINT sweep.
See all Chinese ManufacturersWhat the evidence actually means
Long-form investigations that explain how to read the sources on this platform.
How to read a Certificate of Analysis
Six numbers every buyer should know how to interpret — and the four the industry hopes you skip.
The compounding loophole, mapped
A network analysis of the 503A pharmacies driving the direct-to-consumer peptide market.
Why sterility testing matters
USP <71> in plain English, and what a passing result does — and does not — prove.
Most-researched this week
Latest indexed reports
- Oct 22SemaglutidePassJanoshik · COA-19822
- Oct 21RetatrutideDiscrepancySimec AG · COA-19807
- Oct 20TirzepatidePassJanoshik · COA-19790
- Oct 20BPC-157PendingAnaChem · COA-19771
- Oct 19SermorelinPassJanoshik · COA-19764
| Report ID | Compound | Laboratory | Result | Date |
|---|---|---|---|---|
| COA-19822 | Semaglutide | Janoshik | Pass | Oct 22 |
| COA-19807 | Retatrutide | Simec AG | Discrepancy | Oct 21 |
| COA-19790 | Tirzepatide | Janoshik | Pass | Oct 20 |
| COA-19771 | BPC-157 | AnaChem | Pending | Oct 20 |
| COA-19764 | Sermorelin | Janoshik | Pass | Oct 19 |
From the public record
Regulatory filings, enforcement actions, litigation and research — as they land.
- Regulatory ActionOct 22, 2026
FDA issues warning letters to three compounding pharmacies over sterility documentation
Source · FDA
Oct 22, 2026 - FilingOct 21, 2026
Veritas Longevity Group files S-1 amendment, discloses 3 pending litigation matters
Source · SEC EDGAR
Oct 21, 2026 - EnforcementOct 19, 2026
Florida Board suspends license of two 503A pharmacies pending inspection review
Source · State Board of Pharmacy · FL
Oct 19, 2026 - StudyOct 18, 2026
New meta-analysis on GLP-1 discontinuation weight rebound published in NEJM
Source · PubMed
Oct 18, 2026
Get the week's evidence in your inbox.
New reports, updated dossiers, regulatory actions and lab discrepancies — summarized in five minutes. Free. No affiliate links, ever.